In-silico analysis of identified proteins from HER-2 positive breast cancer cell lines resistant and sensitive to Trastuzumab treatment

In-silico analysis of identified proteins from HER-2 positive breast cancer cell lines resistant and sensitive to Trastuzumab treatment

In-silico analysis of identified proteins from HER-2 positive breast cancer cell lines resistant and sensitive to Trastuzumab treatment 2425 2560 Metabolism & Cancer